Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it
US5091511A · kind A · utility
9Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1989 |
| Grant date | Feb 25, 1992 |
| Priority date | — |
| Expiry date | Sep 25, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/827
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lymphokine activated killer suppressive factor (LAKSF) and a process for producing the LAKSF by cultivating human mono-cytic cells for alveolar macrophages activated by a stimulator to produce LAKSF and harvesting it. The LAKSF has a LAK induction suppressive activity and an immunosuppressive effect and thus the LAKSF is useful as a medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.